Akkermansia muciniphila Akk11

Akkermansia muciniphila Akk11 · Wecare Probiotics Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Akkermansia muciniphila Akk11, covering 2025-11-18 to 2025-11-18. Get the full timeline:

Most recent: Clinical Trial Update: Effect of Akkermansia Muciniphila Akk11 on Metabolic and Gut Health in Overweight and Obese Subjects [NA]